New indications underwriters cant ignore Fatty liver disease (MASH) Formerly known as NASH, metabolic dysfunction associated steatohepatitis is a form of fatty liver disease associated with significantly increased risks of diabetes, heart failure, kidney disease, cirrhosis, and liver cancer
Impaired Exercise Performance: Athletes with a deficiency may notice decreased exercise performance, as L Carnitine is involved in the energy pathways essential for physical activity
And the symptom tracker keeps me body aware! As a girly on a new GLP-1 journey, this app has been such a fun way to track my dosing, symptoms, meals, water, steps and more
(Eli Lilly, which makes another GLP-1 drug, tirzepatide, was also included in the lawsuit.) The new research, based on health insurance claims from 2006 to 2020 from more than 5,000 patients in the U.S., looked at how many people developed one of four serious gastrointestinal problems biliary disease, gastroparesis, pancreatitis or bowel obstructions after they were prescribed one of the weight loss drugs
Why the cause ranges from minor to serious: Temporary pressure on a nerve can resolve in minutes